Promacta [prescribing information]. Novartis Pharmaceuticals Corp. East Hanover, NJ, March 2024. 2. Tavalisse [prescribing information].
Eltrombopag (Promacta) is a thrombopoietin receptor agonist. FDA Promacta Prescribing Information. Research Triangle Park, NC
Promacta. The modified REMS programs will include Healthcare professionals should continue to refer to the drug prescribing information
Eltrombopag (Promacta) prescribing information; Revised March 2024. GSK, Research Triangle Park, NC. 10. Romiplostim (Nplate) prescribing
by H Al‐Samkari 2024 Cited by 77Nplate (romiplostim) [prescribing information]. Thousand Oaks Promacta (eltrombopag) [prescribing information]. Research Triangle
See full prescribing information for. PROMACTA. PROMACTA (eltrombopag) Tablets. For oral use. Initial U.S. Approval: 2024. WARNING:RISK FOR HEPATOTOXICITY. See
Promacta [prescribing information]. GlaxoSmith Kline; November 2024. www.gsksource.com/gskprm/htdocs/documents/PROMACTA-PI-MG-COMBINED.PDF.
Promacta Prescribing Information. East Hanover, NJ: Novartis Pharmaceuticals Corporation;. October 2024. Available at
Eltrombopag Olamine (PROMACTA) Tablets and Powder for Oral Suspension The Product Information should be consulted for detailed prescribing information.
Comments
SHOULD BE:
Andy had literally simply RELAYED all the various information.